Rachael Jetson
Overview
Explore the profile of Rachael Jetson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krieger I, Yalamanchili S, Dickson P, Engelhart C, Zimmerman M, Wood J, et al.
ACS Infect Dis
. 2024 Apr;
10(5):1561-1575.
PMID: 38577994
DNA-encoded chemical library (DEL) technology provides a time- and cost-efficient method to simultaneously screen billions of compounds for their affinity to a protein target of interest. Here we report its...
2.
Ramos A, Goedken E, Frank K, Argiriadi M, Bazzaz S, Bian Z, et al.
J Med Chem
. 2024 Apr;
67(8):6456-6494.
PMID: 38574366
Dysregulation of IL17A drives numerous inflammatory and autoimmune disorders with inhibition of IL17A using antibodies proven as an effective treatment. Oral anti-IL17 therapies are an attractive alternative option, and several...
3.
Collie G, Barlind L, Bazzaz S, Borjesson U, Dale I, Disch J, et al.
Bioorg Med Chem Lett
. 2022 Aug;
75:128948.
PMID: 35987508
The c-MET receptor tyrosine kinase has received considerable attention as a cancer drug target yet there remains a need for inhibitors which are selective for c-MET and able to target...
4.
Nissink J, Bazzaz S, Blackett C, Clark M, Collingwood O, Disch J, et al.
J Med Chem
. 2021 Mar;
64(6):3165-3184.
PMID: 33683117
Mer is a member of the TAM (Tyro3, Axl, Mer) kinase family that has been associated with cancer progression, metastasis, and drug resistance. Their essential function in immune homeostasis has...
5.
Jetson R, Malik N, Luniwal A, Chari V, Ratnam M, Erhardt P
Eur J Med Chem
. 2013 Mar;
63:104-8.
PMID: 23474897
Retinoic acid receptor alpha (RARα) selective compounds may guide the design of drugs that can be used in conjunction with hormonal adjuvant therapy in the treatment of breast cancer. Herein...